Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

Primary antiphospholipid syndrome and antiphospholipid syndrome associated to systemic lupus: Are they different entities?

Belizna C, Stojanovich L, Cohen-Tervaert JW, Fassot C, Henrion D, Loufrani L, Nagy G, Muchardt C, Hasan M, Ungeheuer MN, Arnaud L, Alijotas-Reig J, Esteve-Valverde E, Nicoletti F, Saulnier P, Godon A, Reynier P, Chrétien JM, Damian L, Omarjee L, Mahé G, Pistorius MA, Meroni PL, Devreese K.

Autoimmun Rev. 2018 Aug;17(8):739-745. doi: 10.1016/j.autrev.2018.01.027. Epub 2018 Jun 6. Review.

PMID:
29885541
2.

Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study.

Ruffatti A, Tonello M, Hoxha A, Sciascia S, Cuadrado MJ, Latino JO, Udry S, Reshetnyak T, Costedoat-Chalumeau N, Morel N, Marozio L, Tincani A, Andreoli L, Haladyj E, Meroni PL, Gerosa M, Alijotas-Reig J, Tenti S, Mayer-Pickel K, Simchen MJ, Bertero MT, De Carolis S, Ramoni V, Mekinian A, Grandone E, Maina A, Serrano F, Pengo V, Khamashta MA.

Thromb Haemost. 2018 Apr;118(4):639-646. doi: 10.1055/s-0038-1632388. Epub 2018 Feb 28.

PMID:
29490410
3.

Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review.

Esteve-Valverde E, Ferrer-Oliveras R, Gil-Aliberas N, Baraldès-Farré A, Llurba E, Alijotas-Reig J.

Obstet Gynecol Surv. 2018 Jan;73(1):40-55. doi: 10.1097/OGX.0000000000000522. Review.

PMID:
29368790
4.

Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, LLurba E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, de Carolis S, Rovere-Querini P, Lundelin K, Picardo E, Mekinian A; EUROAPS Study Group.

Med Clin (Barc). 2017 Dec 20. pii: S0025-7753(17)30892-8. doi: 10.1016/j.medcli.2017.11.017. [Epub ahead of print] English, Spanish.

PMID:
29274674
5.

Autoimmune/inflammatory syndrome induced by adjuvants-ASIA-related to biomaterials: analysis of 45 cases and comprehensive review of the literature.

Alijotas-Reig J, Esteve-Valverde E, Gil-Aliberas N, Garcia-Gimenez V.

Immunol Res. 2018 Feb;66(1):120-140. doi: 10.1007/s12026-017-8980-5.

PMID:
29199390
6.

TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion.

Kandhaya-Pillai R, Miro-Mur F, Alijotas-Reig J, Tchkonia T, Kirkland JL, Schwartz S.

Aging (Albany NY). 2017 Nov 22;9(11):2411-2435. doi: 10.18632/aging.101328.

7.

Acquired thrombotic thrombocytopenic purpura and pregnancy: More light than shade but controversies remain.

Alijotas-Reig J.

Thromb Res. 2017 Aug;156:195-197. doi: 10.1016/j.thromres.2017.07.005. Epub 2017 Jul 5. No abstract available.

PMID:
28697902
8.

Maternal microbiota and the major obstetric syndromes: When the enemy becomes an ally.

Tur-Torres MH, Alijotas-Reig J.

Med Clin (Barc). 2018 Feb 23;150(4):141-143. doi: 10.1016/j.medcli.2017.04.008. Epub 2017 May 29. English, Spanish. No abstract available.

PMID:
28571957
9.

Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.

Mekinian A, Alijotas-Reig J, Carrat F, Costedoat-Chalumeau N, Ruffatti A, Lazzaroni MG, Tabacco S, Maina A, Masseau A, Morel N, Esteve-Valverde EE, Ferrer-Oliveras R, Andreoli L, De Carolis S, Josselin-Mahr L, Abisror N, Nicaise-Roland P, Tincani A, Fain O; on the behalf of the SNFMI and the European Forum on Antiphospholipid Antibodies.

Autoimmun Rev. 2017 Jul;16(7):730-734. doi: 10.1016/j.autrev.2017.05.006. Epub 2017 May 4. Review.

PMID:
28478081
10.

Genetics of recurrent miscarriage and fetal loss.

Tur-Torres MH, Garrido-Gimenez C, Alijotas-Reig J.

Best Pract Res Clin Obstet Gynaecol. 2017 Jul;42:11-25. doi: 10.1016/j.bpobgyn.2017.03.007. Epub 2017 Mar 27. Review.

PMID:
28412101
11.

Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Llurba E, Gris JM.

Clin Rev Allergy Immunol. 2017 Aug;53(1):40-53. doi: 10.1007/s12016-016-8596-x. Review.

PMID:
28054230
12.

Pregnancy and autoimmune diseases.

Alijotas-Reig J, Esteve-Valverde E.

Med Clin (Barc). 2017 Feb 23;148(4):161-163. doi: 10.1016/j.medcli.2016.11.008. Epub 2016 Dec 27. English, Spanish. No abstract available.

PMID:
28038858
13.

Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208 cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort.

Alijotas-Reig J, Ferrer-Oliveras R, Esteve-Valverde E, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Espinosa G, Coloma E, de Carolis S, Rovere-Querini P, Canti V, Picardo E, Fredi M, Mekinian A; EUROAPS Study Group.

Am J Reprod Immunol. 2016 Aug;76(2):164-71. doi: 10.1111/aji.12534.

PMID:
27401589
14.

[Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease].

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R.

Med Clin (Barc). 2016 Oct 21;147(8):352-360. doi: 10.1016/j.medcli.2016.05.020. Epub 2016 Jul 5. Review. Spanish.

PMID:
27389618
15.

Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?

Mekinian A, Cohen J, Alijotas-Reig J, Carbillon L, Nicaise-Roland P, Kayem G, Daraï E, Fain O, Bornes M.

Am J Reprod Immunol. 2016 Jul;76(1):8-28. doi: 10.1111/aji.12493. Epub 2016 Feb 5. Review.

PMID:
26847715
16.

Do knowledge of uterine artery resistance in the second trimester and targeted surveillance improve maternal and perinatal outcome? UTOPIA study: a randomized controlled trial.

García B, Llurba E, Valle L, Gómez-Roig MD, Juan M, Pérez-Matos C, Fernández M, García-Hernández JA, Alijotas-Reig J, Higueras MT, Calero I, Goya M, Pérez-Hoyos S, Carreras E, Cabero L.

Ultrasound Obstet Gynecol. 2016 Jun;47(6):680-9. doi: 10.1002/uog.15873.

17.

Obstetric antiphospholipid syndrome.

Esteve-Valverde E, Ferrer-Oliveras R, Alijotas-Reig J.

Rev Clin Esp. 2016 Apr;216(3):135-45. doi: 10.1016/j.rce.2015.09.003. Epub 2015 Oct 23. English, Spanish.

PMID:
26603476
18.
19.

Recurrent miscarriage: causes, evaluation and management.

Garrido-Gimenez C, Alijotas-Reig J.

Postgrad Med J. 2015 Mar;91(1073):151-62. doi: 10.1136/postgradmedj-2014-132672. Epub 2015 Feb 13. Review.

PMID:
25681385
20.

The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study.

Mekinian A, Lazzaroni MG, Kuzenko A, Alijotas-Reig J, Ruffatti A, Levy P, Canti V, Bremme K, Bezanahary H, Bertero T, Dhote R, Maurier F, Andreoli L, Benbara A, Tigazin A, Carbillon L, Nicaise-Roland P, Tincani A, Fain O; SNFMI and the European Forum on Antiphospholipid Antibodies.

Autoimmun Rev. 2015 Jun;14(6):498-502. doi: 10.1016/j.autrev.2015.01.012. Epub 2015 Jan 21. Review.

PMID:
25617818

Supplemental Content

Loading ...
Support Center